Clinical Trial Update: Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis C [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating interferon-alpha lozenges for prevention of relapse in chronic hepatitis C; study completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Interferon Alpha Lozenges (Interferon alpha)

Snippet

Sponsor: Ainos, Inc. (f/k/a Amarillo Biosciences Inc. | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2013-10-31